128 related articles for article (PubMed ID: 33153822)
41. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT
Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053
[TBL] [Abstract][Full Text] [Related]
42. Perinodal fibrosis developed after ultrasonography-guided core-needle biopsy of a contrast-enhanced ultrasound-detected sentinel axillary node interferes with subsequent surgical sentinel node dissection.
Serquiz N; Moro L; Menossi CA; Almeida NR; Baccarin G; de Paiva Silva GR; Shinzato JY; Derchain S; Jales RM
J Clin Ultrasound; 2019 Oct; 47(8):445-452. PubMed ID: 31359458
[TBL] [Abstract][Full Text] [Related]
43. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.
García Fernández A; Chabrera C; García Font M; Fraile M; Lain JM; Barco I; González C; Gónzalez S; Reñe A; Veloso E; Cassadó J; Pessarrodona A; Giménez N
Breast; 2013 Oct; 22(5):902-7. PubMed ID: 23684000
[TBL] [Abstract][Full Text] [Related]
44. Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer.
Rukanskienė D; Veikutis V; Jonaitienė E; Basevičiūtė M; Kunigiškis D; Paukštaitienė R; Čepulienė D; Poškienė L; Boguševičius A
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183080
[No Abstract] [Full Text] [Related]
45. Breast Cancer Patients Undergoing Sentinel Node Biopsy: Additional Axillary Tumor Burden as a Function of the Total Number of Excised Sentinel Nodes-A Multicenter Study.
García-Fernández A; Chabrera C; García-Font M; Giménez N; Barco I; Lain JM; González S; Torras M; Reñe A; González C; Veloso E; Pessarrodona A; Fraile M
Clin Breast Cancer; 2015 Dec; 15(6):490-7. PubMed ID: 26044361
[TBL] [Abstract][Full Text] [Related]
46. Indications for sentinel lymph node biopsy in patients with breast cancer: retrospective and simulation analyses.
Koizumi M; Makita M; Yoshimoto M; Kasumi F; Sakamoto G; Ogata E
Jpn J Clin Oncol; 2002 Dec; 32(12):517-24. PubMed ID: 12578900
[TBL] [Abstract][Full Text] [Related]
47. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
[TBL] [Abstract][Full Text] [Related]
48. The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.
Brahma B; Putri RI; Karsono R; Andinata B; Gautama W; Sari L; Haryono SJ
World J Surg Oncol; 2017 Feb; 15(1):41. PubMed ID: 28173818
[TBL] [Abstract][Full Text] [Related]
49. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.
Plecha D; Bai S; Patterson H; Thompson C; Shenk R
Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365
[TBL] [Abstract][Full Text] [Related]
50. Is sentinel node biopsy reliable in large breast tumors?
Koukouras D; Spyropoulos C; Siasos N; Sdralis E; Tzorakoleftherakis E
Eur J Gynaecol Oncol; 2010; 31(1):80-2. PubMed ID: 20349786
[TBL] [Abstract][Full Text] [Related]
51. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
52. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
53. Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy.
Christin OL; Kuten J; Even-Sapir E; Klausner J; Menes TS
Surg Oncol; 2019 Sep; 30():1-5. PubMed ID: 31500769
[TBL] [Abstract][Full Text] [Related]
54. A predictive tool to estimate the risk of axillary metastases in breast cancer patients with negative axillary ultrasound.
Meretoja TJ; Heikkilä PS; Mansfield AS; Cserni G; Ambrozay E; Boross G; Zgajnar J; Perhavec A; Gazic B; Arisio R; Tvedskov TF; Jensen MB; Leidenius MH
Ann Surg Oncol; 2014 Jul; 21(7):2229-36. PubMed ID: 24664623
[TBL] [Abstract][Full Text] [Related]
55. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer.
Patel NA; Piper G; Patel JA; Malay MB; Julian TB
Am Surg; 2004 Aug; 70(8):696-9; discussion 699-700. PubMed ID: 15328803
[TBL] [Abstract][Full Text] [Related]
56. Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer.
Peña KB; Kepa A; Cochs A; Riu F; Parada D; Gumà J
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435629
[TBL] [Abstract][Full Text] [Related]
57. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
[TBL] [Abstract][Full Text] [Related]
58. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
59. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
60. [Preoperative staging of axillary lymph nodes in breast cancer: ultrasonographic parameters and ultrasound-guided core needle biopsy].
Torres Sousa MY; Banegas Illescas ME; Rozas Rodríguez ML; Arias Ortega M; González López LM; Martín García JJ; Ruiz Ortega L
Radiologia; 2011; 53(6):544-51. PubMed ID: 21565373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]